bearish
Tokyo Kikai Seisakusho (6335) Court Approved Poison Pill Stalemate Extended (Means Selling)
356 Views19 Nov 2021 10:55
SUMMARY
- On 17 November, Tokyo Kikai Seisakusho (6335 JP) announced an agreement with ADC to hold off on issuing the rights against an ADC pledge to not call an EGM.
- On 18 November, the Supreme Court handed down its rejection of the Asia Development Capital (9318 JP) appeals.
- The immediate hostility is dialled back, the stalemate is extended. Every buyer from now on is a potential bagholder.
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Tokyo Kikai Seisakusho (6335) Court Approved Poison Pill Stalemate Extended (Means Selling)19 Nov 2021
- Tokyo Kikai Seisakusho (6335) - Poison Pill Approval Appealed and Possible Silver Linings01 Nov 2021
- Tokyo Kikai Seisakusho (6335) - Shareholders Approve Poison Pill23 Oct 2021
x